Foster & Motley’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.51M | Sell |
17,916
-1,631
| -8% | -$317K | 0.18% | 128 |
|
|
2025
Q4 | $3.39M | Sell |
19,547
-5,015
| -20% | -$913K | 0.18% | 127 |
|
|
2025
Q3 | $4.68M | Sell |
24,562
-4,223
| -15% | -$749K | 0.25% | 101 |
|
|
2025
Q2 | $5.17M | Sell |
28,785
-1,844
| -6% | -$320K | 0.3% | 90 |
|
|
2025
Q1 | $5.18M | Sell |
30,629
-1,735
| -5% | -$285K | 0.33% | 82 |
|
|
2024
Q4 | $4.88M | Sell |
32,364
-1,352
| -4% | -$210K | 0.32% | 81 |
|
|
2024
Q3 | $5.23M | Sell |
33,716
-2,362
| -7% | -$353K | 0.33% | 83 |
|
|
2024
Q2 | $4.94M | Sell |
36,078
-952
| -3% | -$130K | 0.34% | 80 |
|
|
2024
Q1 | $4.93M | Sell |
37,030
-3,140
| -8% | -$407K | 0.34% | 83 |
|
|
2023
Q4 | $5.54M | Sell |
40,170
-529
| -1% | -$69.5K | 0.41% | 65 |
|
|
2023
Q3 | $4.96M | Buy |
40,699
+898
| +2% | +$120K | 0.41% | 62 |
|
|
2023
Q2 | $5.59M | Buy |
39,801
+965
| +2% | +$133K | 0.43% | 58 |
|
|
2023
Q1 | $5.5M | Buy |
38,836
+7,062
| +22% | +$1.01M | 0.45% | 55 |
|
|
2022
Q4 | $4.97M | Buy |
31,774
+3,395
| +12% | +$488K | 0.42% | 60 |
|
|
2022
Q3 | $3.48M | Sell |
28,379
-313
| -1% | -$41.2K | 0.33% | 77 |
|
|
2022
Q2 | $3.81M | Sell |
28,692
-732
| -2% | -$99.7K | 0.34% | 70 |
|
|
2022
Q1 | $4.03M | Sell |
29,424
-762
| -3% | -$106K | 0.32% | 80 |
|
|
2021
Q4 | $5.22M | Buy |
30,186
+994
| +3% | +$151K | 0.41% | 64 |
|
|
2021
Q3 | $4.24M | Buy |
29,192
+318
| +1% | +$46.5K | 0.35% | 73 |
|
|
2021
Q2 | $3.81M | Buy |
28,874
+738
| +3% | +$96.6K | 0.32% | 81 |
|
|
2021
Q1 | $3.61M | Buy |
28,136
+3,401
| +14% | +$419K | 0.3% | 82 |
|
|
2020
Q4 | $2.95M | Buy |
24,735
+5,654
| +30% | +$689K | 0.28% | 93 |
|
|
2020
Q3 | $2.19M | Buy |
19,081
+963
| +5% | +$114K | 0.26% | 107 |
|
|
2020
Q2 | $2.06M | Buy |
18,118
+4,790
| +36% | +$508K | 0.26% | 103 |
|
|
2020
Q1 | $1.07M | Buy |
13,328
+8,518
| +177% | +$882K | 0.16% | 129 |
|
|
2019
Q4 | $514K | Sell |
4,810
-54
| -1% | -$5.63K | 0.06% | 191 |
|
|
2019
Q3 | $521K | Buy |
4,864
+38
| +0.8% | +$3.9K | 0.07% | 186 |
|
|
2019
Q2 | $491K | Sell |
4,826
-279
| -5% | -$26.8K | 0.07% | 187 |
|
|
2019
Q1 | $459K | Hold |
5,105
| – | – | 0.07% | 182 |
|
|
2018
Q4 | $425K | Sell |
5,105
-915
| -15% | -$85.8K | 0.07% | 179 |
|
|
2018
Q3 | $650K | Sell |
6,020
-389
| -6% | -$42.7K | 0.1% | 152 |
|
|
2018
Q2 | $705K | Sell |
6,409
-32
| -0.5% | -$3.33K | 0.11% | 148 |
|
|
2018
Q1 | $646K | Sell |
6,441
-292
| -4% | -$29.9K | 0.11% | 144 |
|
|
2017
Q4 | $663K | Buy |
6,733
+925
| +16% | +$87.7K | 0.11% | 144 |
|
|
2017
Q3 | $544K | Buy |
5,808
+3,798
| +189% | +$403K | 0.09% | 147 |
|
|
2017
Q2 | $223K | Buy |
+2,010
| New | +$213K | 0.04% | 189 |
|
Other funds holding DGX
VCM
VPM
EIG
Foster & Motley's DGX Position: Q1 2026 in Review
Foster & Motley reduced its Quest Diagnostics (DGX) stake by 8.3% in Q1 2026, selling an estimated $317K and leaving 17,916 shares worth $3.51M. The position accounts for 0.18% of the portfolio, ranked #128.
Foster & Motley first reported a position in DGX in Q2 2017 and has held it in 36 quarters since. The position peaked at $5.59M in Q2 2023. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Foster & Motley held 17,916 shares of Quest Diagnostics worth $3.51M as of Q1 2026.
- Foster & Motley sold 1,631 Quest Diagnostics shares in Q1 2026, an estimated $317K.
- Quest Diagnostics made up 0.18% of Foster & Motley's portfolio in Q1 2026, its #128 holding.
- Foster & Motley first reported a position in Quest Diagnostics in Q2 2017 and has held it in 36 quarters since.
- Foster & Motley's Quest Diagnostics position peaked at $5.59M in Q2 2023.
- 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Foster & Motley's 13F filing for Q1 2026, filed 21 Apr 2026.